Literature DB >> 12555935

Short-term dietary interventions in children and adolescents with treated phenylketonuria: effects on neuropsychological outcome of a well-controlled population.

S C J Huijbregts1, L M J de Sonneville, R Licht, F J van Spronsen, J A Sergeant.   

Abstract

This study addressed two questions: is there an effect of dietary interventions that induce relatively small changes in phenylalanine (Phe) concentration on neuropsychological outcome of early- and continuously treated phenylketonuria (PKU) patients, and are there differences in effects for PKU children and adolescents? To answer the first question, the effect of a short-term dietary intervention (1-2 weeks) was compared for patients whose Phe concentrations increased vs those whose Phe concentrations decreased. Controls were tested twice to control for learning effects. To answer the second question, the effect of dietary interventions was examined in younger patients (aged 7-10 years) and older patients (aged 11-14 years). The effect of dietary interventions was determined with three neuropsychological tasks: one requiring sustained attention; a second demanding maintenance in working memory; and a third in which complex operations were performed in working memory. Relatively small fluctuations in Phe concentration were found to influence neuropsychological task performance of PKU patients. Patients whose Phe concentrations decreased at the second assessment showed generally more improvement than controls. Patients whose Phe concentrations had increased showed minimal improvement or deterioration of task performance. The strongest effects were observed when sustained attention and manipulation of working memory content were required. There were some indications of a greater sensitivity of younger patients to fluctuations in Phe concentration.

Entities:  

Mesh:

Year:  2002        PMID: 12555935     DOI: 10.1023/a:1021205713674

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  29 in total

1.  Brain development during childhood and adolescence: a longitudinal MRI study.

Authors:  J N Giedd; J Blumenthal; N O Jeffries; F X Castellanos; H Liu; A Zijdenbos; T Paus; A C Evans; J L Rapoport
Journal:  Nat Neurosci       Date:  1999-10       Impact factor: 24.884

Review 2.  Relationships among processing speed, working memory, and fluid intelligence in children.

Authors:  A F Fry; S Hale
Journal:  Biol Psychol       Date:  2000-10       Impact factor: 3.251

3.  Localization of a human system for sustained attention by positron emission tomography.

Authors:  J V Pardo; P T Fox; M E Raichle
Journal:  Nature       Date:  1991-01-03       Impact factor: 49.962

4.  A quantitative magnetic resonance imaging study of changes in brain morphology from infancy to late adulthood.

Authors:  A Pfefferbaum; D H Mathalon; E V Sullivan; J M Rawles; R B Zipursky; K O Lim
Journal:  Arch Neurol       Date:  1994-09

5.  Neuropsychology of early-treated phenylketonuria: specific executive function deficits.

Authors:  M C Welsh; B F Pennington; S Ozonoff; B Rouse; E R McCabe
Journal:  Child Dev       Date:  1990-12

Review 6.  Convergence and plasticity of monoaminergic systems in the medial prefrontal cortex during the postnatal period: implications for the development of psychopathology.

Authors:  F M Benes; J B Taylor; M C Cunningham
Journal:  Cereb Cortex       Date:  2000-10       Impact factor: 5.357

7.  Prefrontal cortex cognitive deficits in children treated early and continuously for PKU.

Authors:  A Diamond; M B Prevor; G Callender; D P Druin
Journal:  Monogr Soc Res Child Dev       Date:  1997

8.  Mesocortical dopamine neurons: rapid transmitter turnover compared to other brain catecholamine systems.

Authors:  M J Bannon; E B Bunney; R H Roth
Journal:  Brain Res       Date:  1981-08-10       Impact factor: 3.252

9.  EEGs in phenylketonuria. I: Follow-up to adulthood; II: Short-term diet-related changes in EEGs and cognitive function.

Authors:  J Pietz; E Schmidt; P Matthis; B Kobialka; A Kutscha; L de Sonneville
Journal:  Dev Med Child Neurol       Date:  1993-01       Impact factor: 5.449

10.  Biochemical and neuropsychological effects of elevated plasma phenylalanine in patients with treated phenylketonuria. A model for the study of phenylalanine and brain function in man.

Authors:  W Krause; M Halminski; L McDonald; P Dembure; R Salvo; D Freides; L Elsas
Journal:  J Clin Invest       Date:  1985-01       Impact factor: 14.808

View more
  10 in total

1.  Living situation, occupation and health-related quality of life in adult patients with classic galactosemia.

Authors:  Björn Hoffmann; Nico Dragano; Susanne Schweitzer-Krantz
Journal:  J Inherit Metab Dis       Date:  2012-03-24       Impact factor: 4.982

2.  Predictability and inconsistencies in the cognitive outcome of early treated PKU patients.

Authors:  Filippo Manti; Francesca Nardecchia; Sabrina Paci; Flavia Chiarotti; Claudia Carducci; Carla Carducci; Silvia Dalmazzone; Graziella Cefalo; Elisabetta Salvatici; Giuseppe Banderali; Vincenzo Leuzzi
Journal:  J Inherit Metab Dis       Date:  2017-08-23       Impact factor: 4.982

Review 3.  Modelling inborn errors of metabolism in zebrafish.

Authors:  Kim Wager; Fahad Mahmood; Claire Russell
Journal:  J Inherit Metab Dis       Date:  2014-05-06       Impact factor: 4.982

Review 4.  The truth of treating patients with phenylketonuria after childhood: the need for a new guideline.

Authors:  F J van Spronsen; P Burgard
Journal:  J Inherit Metab Dis       Date:  2008-08-12       Impact factor: 4.982

Review 5.  Consequences of variations in genes that affect dopamine in prefrontal cortex.

Authors:  Adele Diamond
Journal:  Cereb Cortex       Date:  2007-09       Impact factor: 5.357

6.  Meta-analysis of neuropsychological symptoms of adolescents and adults with PKU.

Authors:  J J Moyle; A M Fox; M Arthur; M Bynevelt; J R Burnett
Journal:  Neuropsychol Rev       Date:  2007-04-05       Impact factor: 7.444

7.  High phenylalanine levels directly affect mood and sustained attention in adults with phenylketonuria: a randomised, double-blind, placebo-controlled, crossover trial.

Authors:  Amber E ten Hoedt; Leo M J de Sonneville; Baudouin Francois; Nienke M ter Horst; Mirian C H Janssen; M Estela Rubio-Gozalbo; Frits A Wijburg; Carla E M Hollak; Annet M Bosch
Journal:  J Inherit Metab Dis       Date:  2010-12-10       Impact factor: 4.982

8.  Assessment of the impact of phenylketonuria and its treatment on quality of life of patients and parents from seven European countries.

Authors:  Annet M Bosch; Alberto Burlina; Amy Cunningham; Esther Bettiol; Flavie Moreau-Stucker; Ekaterina Koledova; Khadra Benmedjahed; Antoine Regnault
Journal:  Orphanet J Rare Dis       Date:  2015-06-18       Impact factor: 4.123

9.  Efficacy and safety of sapropterin dihydrochloride in patients with phenylketonuria: A meta-analysis of randomized controlled trials.

Authors:  Jinghan Qu; Ting Yang; Ente Wang; Min Li; Chaoyang Chen; Lingyun Ma; Ying Zhou; Yimin Cui
Journal:  Br J Clin Pharmacol       Date:  2019-03-18       Impact factor: 4.335

10.  Executive functioning, adaptive skills, emotional and behavioral profile: A comparison between autism spectrum disorder and phenylketonuria.

Authors:  Barbara Trimarco; Filippo Manti; Francesca Nardecchia; Sergio Melogno; Mara Testa; Giovanni Meledandri; Claudia Carducci; Roberta Penge; Vincenzo Leuzzi
Journal:  Mol Genet Metab Rep       Date:  2020-03-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.